FBN1 and progeroid syndrome: Asprosin was first identified by Romere et al., who also verified that patients with neonatal progeroid syndrome have mutations at the 3' terminus of the fibrillin-1 (FBN-1) gene that cause asprosin to be absent near the C-terminal cleavage site [8].